Drug Name | Roaccutane(Isotretinoin) |
---|---|
Drug Class | |
Risk minimization type |
Direct Healthcare Professional Communication DHPC
|
Specialty (Theraputic area) |
Dermatology
|
Risk |
Risk of teratogenicity . |
patient guide |
|
patient consent form |
|
Dear Healthcare provider letter DHPC |
|
other |
Contraception information brochure for ISOTRETINOIN PATIENTS DHPC 11/09/2019 |